Spirometry versus airwave oscillometry for assessment of mepolizumab efficacy in severe eosinophilic asthma

Tuesday, January 25th, 2022

This study compared spirometry using the Vitalograph Alpha device versus airwave oscillometry for assessing the efficacy of mepolizumab in 13 patients with severe eosinophilic asthma. Endpoints of interest included FeNO, blood eosinophils, induced sputum eosinophils, symptoms, and QoL.